ACADIA Pharmaceuticals
ACAD
#3449
Rank
โ‚ฌ3.78 B
Marketcap
22,09ย โ‚ฌ
Share price
-0.47%
Change (1 day)
20.70%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): โ‚ฌ0.12 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ1.07 Billion. a decrease over its 2024 earnings that were of โ‚ฌ0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ0.12 B-46.18%
2024 โ‚ฌ0.22 B-605.67%
2023 -โ‚ฌ44.74 Million-76.09%
2022 -โ‚ฌ0.19 Billion27.41%
2021 -โ‚ฌ0.15 Billion-40.38%
2020 -โ‚ฌ0.25 Billion19.88%
2019 -โ‚ฌ0.21 Billion-3.92%
2018 -โ‚ฌ0.22 Billion-15.04%
2017 -โ‚ฌ0.26 Billion6.33%
2016 -โ‚ฌ0.24 Billion64.55%
2015 -โ‚ฌ0.15 Billion77.47%
2014 -โ‚ฌ81.06 Million143.69%
2013 -โ‚ฌ33.27 Million81.93%
2012 -โ‚ฌ18.29 Million-8.73%
2011 -โ‚ฌ20.03 Million-251.39%
2010 โ‚ฌ13.23 M-133.2%
2009 -โ‚ฌ39.86 Million-30.82%
2008 -โ‚ฌ57.61 Million6.43%
2007 -โ‚ฌ54.13 Million25.89%
2006 -โ‚ฌ43 Million36.99%
2005 -โ‚ฌ31.39 Million37.22%
2004 -โ‚ฌ22.88 Million19.96%
2003 -โ‚ฌ19.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.77 B 18,602.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ9.28 B 7,524.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ27.28 B 22,307.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.41 B 6,809.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-โ‚ฌ0.11 Billion-187.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-โ‚ฌ33.86 Million-127.81%๐Ÿ‡บ๐Ÿ‡ธ USA